top of page

Animal research shows miR-224 contributes to PAH

Sep 8
1 min read

A small molecule called microRNA-224-5p (miR-224) appears to play an important role in the changes to the lung blood vessels that occur in pulmonary arterial hypertension (PAH). Researchers found that miR-224 levels were higher in cells from people with PAH and in several animal models, and that increasing miR-224 worsened the disease.


In contrast, blocking miR-224 reduced abnormal blood vessel changes and improved right heart function in mice and rats.


The researchers believe miR-224 contributes to PAH by disrupting the balance between two signalling pathways that control blood vessel cell growth. Blocking miR-224 could be a potential new treatment approach for PAH.


 
 
 

Recent Posts

What affects physical activity for people with PH?

A UK study examined the factors that affected physical activity participation among people with pulmonary hypertension (PH). They found four themes: fear of breathlessness; lack of motivation and a de

 
 
 

3 Comments


Kari Maru
Sep 29

If you love the thrill of head-to-head competition, the game makes every second on the court count, as the difference between a successful attack and a turnover can hinge on a split-second decision. Basketball Stars

Like

That’s fascinating how miR‑224 affects PAH in animals—blocking it helped their hearts! Speaking of keeping things in sync, a presentation timer can help you stay on track during science talks.

Like

Abbey Lee
Sep 19

Been browsing Poki Games when I need to unwind after long study sessions. They organize everything by category which makes it easy to find something that matches your mood. The multiplayer section has some surprisingly fun stuff too.

Like

PHA Canada

408 - 55 Water Street

Office 8928

Vancouver, BC, V6B 1A1

Email: info@phacanada.ca

Phone: 604-682-1036

Toll Free: 1-877-774-2226

Charitable Registration # 872050224RR0001

  • Instagram
  • Facebook
  • X
  • LinkedIn
  • Youtube

Copyright 2025 PHA CANADA, ALL RIGHTS RESERVED   |   Website created by Creativibe

bottom of page